Page last updated: 2024-11-06

hydroxyproline and Hepatolenticular Degeneration

hydroxyproline has been researched along with Hepatolenticular Degeneration in 2 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asatoor, AM2
Milne, MD1
Walshe, JM2
Miline, MD1

Other Studies

2 other studies available for hydroxyproline and Hepatolenticular Degeneration

ArticleYear
Peptiduria in the Fanconi syndrome.
    Ciba Foundation symposium, 1977, Issue:50

    Topics: Animals; Fanconi Syndrome; Hepatolenticular Degeneration; Humans; Hydroxyproline; Maleates; Peptides

1977
Urinary excretion of peptides and of hydroxyproline in Wilson's disease.
    Clinical science and molecular medicine, 1976, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Amino Acids; Child; Collagen; Copper; Female; Hepatolenticular Degeneration; Huma

1976